Butabarbital decreases outcomes of hemin by pharmacodynamic antagonism. Use Caution/Monitor. Medicine that increase delta-aminolevulinic acid synthetase may well decrease hemin impact. butabarbital will decrease the level or outcome of levamlodipine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. buprenorphine, extended-performing injection and butabarbital the two maximize ... https://roberts122bby0.wikinarration.com/user